Home › Funds › PFM Health Sciences, LP › HSIC
PFM Health Sciences, LP position in HSIC
SCHEIN HENRY INC · Health Care
PFM Health Sciences, LP reported holding 134,423 shares of HSIC (SCHEIN HENRY INC) in its Q2 2026 13F filing — a position valued at US$11.2M, representing 0.98% of its reported portfolio and ranking #39 among its reported holdings. PFM Health Sciences, LP has disclosed HSIC holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's HSIC position evolved
PFM Health Sciences, LP first disclosed a stake in HSIC in Q1 2026 at 153,114 shares (US$11.3M). Across 2 filings, PFM Health Sciences, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 134,423 shares valued at US$11.2M — a reduction of -18,691 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 153.11K | $11.28M | New |
| Q2 2026 | 134.42K | $11.23M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HSIC and 13F data
HSIC (SCHEIN HENRY INC) is a Health Care company. 27 other funds we track also report a position in HSIC — the largest reported positions include Kohlberg Kravis Roberts & Co. L.P. (US$1.31B), Artisan Partners Limited Partnership (US$540.2M), Southpoint Capital Advisors LP (US$275.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HSIC
- Kohlberg Kravis Roberts & Co. L.P. 15.65M sh · $1.31B · Q2 2026
- Artisan Partners Limited Partnership 6.47M sh · $540.16M · Q2 2026
- Southpoint Capital Advisors LP 3.30M sh · $275.62M · Q2 2026
- Palestra Capital Management LLC 2.45M sh · $204.35M · Q2 2026
- FIDUCIARY MANAGEMENT INC /WI/ 1.82M sh · $151.79M · Q2 2026
- LYRICAL ASSET MANAGEMENT LP 1.47M sh · $122.55M · Q2 2026
- M.D. Sass, LLC 1.29M sh · $107.49M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 1.29M sh · $107.34M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held HSIC?
PFM Health Sciences, LP has disclosed HSIC holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is PFM Health Sciences, LP's current position in HSIC?
As of Q2 2026, PFM Health Sciences, LP holds 134.42K shares of HSIC (SCHEIN HENRY INC), valued at $11.23M, representing 0.98% of its reported portfolio and ranking #39.
Has PFM Health Sciences, LP been buying or selling HSIC?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in HSIC.
Which other funds hold HSIC?
Other major institutional holders of HSIC include Kohlberg Kravis Roberts & Co. L.P., Artisan Partners Limited Partnership, Southpoint Capital Advisors LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.